Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers and develops novel drugs that address serious unmet medical needs in patients with cancers associated with abnormal gene expression. Its integrated epigenetics platform helps to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity.